Nephrology focuses on diagnosing and treating kidney diseases. The kidneys filter waste, balance fluids, regulate blood pressure, and manage acute and chronic conditions.
Send us all your questions or requests, and our expert team will assist you.
Effective treatment and follow‑up are critical for patients diagnosed with Hemolytic Uremic Syndrome (HUS), a condition that can rapidly impair kidney function and threaten multiple organ systems. At Liv Hospital, our multidisciplinary team combines cutting‑edge therapies with personalized after‑care to optimize recovery and minimize long‑term complications. Recent studies indicate that early intervention can reduce the need for chronic dialysis by up to 40 %, underscoring the importance of swift, coordinated care.
This page outlines the full continuum of care—from emergency stabilization to long‑term surveillance—specifically designed for international patients seeking world‑class nephrology services. Whether you are a patient, a family member, or a referring physician, you will find clear guidance on what to expect during hospitalization, the therapeutic options available, and the structured follow‑up program that ensures ongoing health monitoring.
Our approach integrates evidence‑based medicine, state‑of‑the‑art technology, and comprehensive support services such as interpreter assistance, transportation, and accommodation coordination, making the entire journey as seamless as possible.
The first 24 hours after a suspected HUS diagnosis focus on rapid assessment and stabilization. Prompt identification of hemolysis, thrombocytopenia, and acute kidney injury guides the intensity of care required.
Critical care teams employ a bundle of interventions aimed at preserving organ perfusion and preventing further hemolysis:
At Liv Hospital, patients are monitored in a dedicated nephrology intensive care unit equipped with continuous renal replacement therapy (CRRT) capabilities, allowing immediate escalation to dialysis if needed.
Beyond supportive care, targeted therapies address the underlying pathophysiology of HUS. The choice of treatment depends on whether the syndrome is typical (Shiga‑toxin associated) or atypical (complement‑mediated).
Plasma exchange (PLEX) removes circulating toxins and autoantibodies while replenishing functional complement regulators. A typical regimen involves daily exchanges of 1–1.5 plasma volumes for 5–7 days.
For complement‑mediated HUS, monoclonal antibodies that inhibit C5 (eculizumab) or its long‑acting counterpart (ravulizumab) have transformed outcomes. Dosing follows a weight‑based schedule, with induction doses administered weekly for the first month.
When acute kidney injury progresses, intermittent hemodialysis or continuous therapies are employed. Table 1 summarizes the indications for each modality.
Even with aggressive therapy, many HUS survivors develop varying degrees of chronic kidney disease (CKD). Early identification and intervention can slow progression.
Patients whose eGFR falls below 15 mL/min/1.73 m² despite maximal medical therapy are evaluated for renal replacement options. Liv Hospital’s transplant program offers pre‑emptive living‑donor transplantation, with a coordinated international referral pathway.
Understanding medication adherence, fluid management, and signs of uremia empowers patients to participate actively in their care. Educational brochures are provided in multiple languages, and tele‑consultations are available for follow‑up visits.
HUS can affect systems beyond the kidneys, including the central nervous system, gastrointestinal tract, and cardiovascular system. A structured surveillance plan is essential for early detection of late complications.
Annual renal ultrasound evaluates cortical thickness and scarring. For patients with prior neurological involvement, brain MRI is repeated at 12 months and then as clinically indicated.
Chronic illness can lead to anxiety, depression, or post‑traumatic stress. Liv Hospital’s counseling unit offers virtual and in‑person sessions, with multilingual therapists familiar with the cultural nuances of international patients.
Optimal nutrition supports renal healing and overall resilience. Our dietitians design individualized meal plans that respect cultural preferences and dietary restrictions.
Gradual re‑introduction of aerobic exercise—starting with 10‑15 minutes of walking three times per week—helps improve cardiovascular fitness without overtaxing compromised kidneys. Physical therapists provide customized programs and remote monitoring tools.
Both smoking and excessive alcohol accelerate CKD progression. Patients receive counseling, nicotine replacement options, and referrals to specialized cessation clinics.
Seamless continuity of care is a hallmark of Liv Hospital’s approach, especially for patients traveling from abroad. Our treatment and follow‑up pathway integrates hospital‑based services with home‑based monitoring.
Patients receive a Bluetooth‑enabled blood pressure cuff and a mobile app that logs daily weights, urine output, and medication adherence. Data are reviewed by our nephrology team in real time, allowing rapid intervention if trends suggest deterioration.
Our International Patient Services team coordinates airport transfers, hotel bookings, and interpreter services. They also assist with medical visa applications, ensuring that patients can focus on recovery rather than logistics.
Liv Hospital is JCI‑accredited and specializes in complex nephrology cases, offering a blend of advanced technology, multilingual expertise, and comprehensive patient support. International patients benefit from a 360‑degree service model that includes dedicated case managers, state‑of‑the‑art intensive care units, and a proven track record in managing Hemolytic Uremic Syndrome.
Ready to discuss your personalized treatment and follow‑up plan? Contact our International Patient Services team today to arrange a virtual consultation and start your journey toward recovery with confidence.
Liv Hospital Vadistanbul
Prof. MD. Süleyman Tevfik Ecder
Nephrology
Liv Hospital Bahçeşehir
Asst. Prof. MD. Himmet Bora Uslu
Nephrology
Liv Hospital Bahçeşehir
Prof. MD. Mehmet Taşdemir
Pediatric Nephrology
Liv Hospital Bahçeşehir
Prof. MD. Ozan Özkaya
Pediatric Nephrology
Liv Hospital Ankara
Prof. MD. Hüsnü Oğuz Söylemezoğlu
Pediatric Nephrology
Liv Bona Dea Hospital Bakü
MD. FERHAD ŞİRİNOV
Nephrology
Send us all your questions or requests, and our expert team will assist you.
Within the first day after a suspected Hemolytic Uremic Syndrome diagnosis, clinicians obtain a complete blood count with peripheral smear, serum creatinine and urea, complement levels, ADAMTS13 activity, and urinalysis. These tests confirm microangiopathic hemolytic anemia, evaluate renal function, and differentiate atypical HUS from TTP. Simultaneously, patients receive fluid resuscitation, blood pressure control, and transfusions as needed to preserve perfusion and prevent further hemolysis.
For Shiga‑toxin‑associated (typical) HUS, treatment is mainly supportive: careful fluid management, blood pressure control, and renal replacement when needed. Atypical, complement‑mediated HUS benefits from targeted therapies such as plasma exchange to remove autoantibodies and monoclonal antibodies like eculizumab or ravulizumab that block complement component C5. Dosing is weight‑based with weekly induction for the first month, followed by maintenance infusions.
If acute kidney injury progresses despite conservative measures, clinicians initiate renal replacement. Intermittent hemodialysis is used when patients are hemodynamically stable, whereas continuous renal replacement therapy (CRRT) is preferred for unstable patients, severe fluid overload, or rapid correction of hyperkalemia. The choice is individualized based on the patient’s cardiovascular status and the urgency of toxin clearance.
The hospital assigns a case manager who arranges airport transfers, visa assistance, hotel bookings, and interpreter services. After discharge, patients receive a Bluetooth‑enabled blood pressure cuff and a mobile app to log daily weights, urine output, and medication adherence. Data are reviewed in real time by the nephrology team, and tele‑medicine appointments are scheduled at 1 week, 1 month, 3 months, and 6 months to ensure continuity of care.
Liv Hospital’s surveillance plan includes CBC and reticulocyte count every six months, annual complement levels for atypical HUS, lipid and glucose panels for cardiovascular risk, and yearly renal ultrasound to assess cortical thickness. Patients with prior neurological involvement receive brain MRI at 12 months and as needed. Additionally, psychosocial counseling is offered to address anxiety, depression, or post‑traumatic stress related to chronic illness.
BlogHemolytic UremicMay 07, 2026Discover the essential steps to treat HUS and regain your health. Our comprehensive guide covers the latest...
BlogHemolytic UremicMay 07, 2026Get informed about HUS disease - learn the 5 crucial facts to know about this rare but critical health cond...
BlogHemolytic UremicMay 07, 2026Learn about erythroblastosis fetalis, a dangerous condition where maternal antibodies attack fetal red bloo...
BlogHemolytic UremicMay 07, 2026Understanding your body’s inner workings is key to good health. At Liv Hospital, we think knowing is ...
BlogHemolytic UremicApr 14, 2026Learn the essential steps to identify and manage intravascular hemolysis for optimal patient outcomes.
BlogHemolytic UremicApr 14, 2026Discover the 7 key symptoms of HUS, the dangerous E. coli complication. Our article provides a comprehensiv...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 28 17